Intellectual Property for Pharma Regulatory Affairs 2018
In-Person Event
Nov 05, 2018
London, England, GBSpeakers
OVERVIEW
Intellectual Property for Pharma Regulatory Affairs is organized by Management Forum (Mf) Ltd and will be held on Nov 05, 2018 at The Rembrandt Hotel, London, England, United Kingdom.
The target audience for this medical event is will be of interest to development and regulatory managers working in the pharmaceutical industry. It will also be relevant to anyone requiring an overview of the key IP issues relating to regulatory affairs.
Course Overview:
This practical one day course will provide an overview of Intellectual Property (IP) for those working in Regulatory Affairs.
IP is a fundamental contributing factor to the overall regulatory strategic approach that a company may take and recognition of the different aspects of IP and influences is essential in modern regulatory affairs. Attendance will enable you to understand IP aspects and their impact and influence on regulatory strategy. Key issues covered will include patents, trademarks and copyright as well as Data and Market Exclusivity for global pharmaceutical products. The course will also discuss the EU and FDA regulatory process, highlighting one of the fundamental differences between EU and US systems and the link to patents.
Benefits in attending:
• Gain an overview of IP and how it contributes to a company’s overall regulatory strategy
• Understand key IP issues including patents, copyright and freedom to operate and how they impact on regulatory affairs
• Discuss data and market exclusivity for global pharmaceutical products
• Discuss EU & FDA regulatory processes, their differences and the link to patents
Tickets :
• Course Fee in GBP 599.00 book before Sep 21, 2018, after that GBP 699.00 upto Nov 04, 2018.
• Course Fee in EUR 839.00 book before Sep 21, 2018, after that EUR 979.00 upto Nov 04, 2018.
Additional details will be posted as soon as they are available.
The target audience for this medical event is will be of interest to development and regulatory managers working in the pharmaceutical industry. It will also be relevant to anyone requiring an overview of the key IP issues relating to regulatory affairs.
Course Overview:
This practical one day course will provide an overview of Intellectual Property (IP) for those working in Regulatory Affairs.
IP is a fundamental contributing factor to the overall regulatory strategic approach that a company may take and recognition of the different aspects of IP and influences is essential in modern regulatory affairs. Attendance will enable you to understand IP aspects and their impact and influence on regulatory strategy. Key issues covered will include patents, trademarks and copyright as well as Data and Market Exclusivity for global pharmaceutical products. The course will also discuss the EU and FDA regulatory process, highlighting one of the fundamental differences between EU and US systems and the link to patents.
Benefits in attending:
• Gain an overview of IP and how it contributes to a company’s overall regulatory strategy
• Understand key IP issues including patents, copyright and freedom to operate and how they impact on regulatory affairs
• Discuss data and market exclusivity for global pharmaceutical products
• Discuss EU & FDA regulatory processes, their differences and the link to patents
Tickets :
• Course Fee in GBP 599.00 book before Sep 21, 2018, after that GBP 699.00 upto Nov 04, 2018.
• Course Fee in EUR 839.00 book before Sep 21, 2018, after that EUR 979.00 upto Nov 04, 2018.
Additional details will be posted as soon as they are available.
KEY DATES
05 Nov, 2018
Event Start Date
05 Nov, 2018
Event End Date
SPECIALITIES
Pharmacy and MedicineSUGGESTED HOTELS
CONFERENCE VENUE
The Rembrandt HotelRELATED CONFERENCES & LIVE WEBINARS
Quick Links